The use of tumor markers such as CEA (carcinoembryonic antigen) and CA-15.3 (often elevated in breast carcinomas) in routine CSF examinations has shown promising results, especially in relation to leptomeningeal metastases.16 This evidence concerns the gene CEACAM5 and breast carcinoma.